Montefiore continues to occupy a position in the top tier of U.S. News and World Report’s Best Hospital rankings for 2017–2018. This annual look at hospitals across the country provides valuable information for healthcare consumers seeking the best care.
Placing again in the top 1% for specialty care in Diabetes & Endocrinology, Montefiore also continues to rank among the top 10% in Cancer, Gastroenterology, Geriatrics, Nephrology, Neurology, Pulmonology, Urology, Coronary Artery Bypass Grafting (CABG), heart failure (CHF), Colon Cancer Surgery, and Chronic Obstructive Pulmonary Disease (COPD).
PLACES US AMONG
THE NATION’S TOP
In addition to Montefiore’s strong performance on the national level, we rank in the top 10 both in the State of New York and the New York Metro area. This is a notable achievement in a region of the country with an extraordinary concentration of high performing medical institutions.
Montefiore and our Einstein College of Medicine embrace the principle of doing more for every patient in every community we serve. Discovering new lifesaving treatments, deploying the latest technologies and delivering the coordinated, compassionate care every patient deserves keeps Montefiore in the top tier of the nation’s hospitals.
Montefiore Pediatric Diabetes and Endocrinology Nurse Practitioners Amy Dowd, CPNP, Rebecca Crespi, CPNP, and Leigh Pughe, CPNP, with Z100’s Garrett Vogel.
Diabetes is no walk in the park for a child, but thanks to Children’s Hospital at Montefiore (CHAM) it can be a trip to the zoo. CHAM’s Division of Pediatric Endocrinology and Diabetes hosted their 6th Annual Family Diabetes Day at the Bronx Zoo on July 25, for about 200 patients and family members. Fun and inspiration were on tap with Z100 D.J. Garrett Vogel discussing his own experiences with type 1 diabetes. Other speakers included an attorney who shared information about education rights; a counselor from Camp Nejeda, New Jersey, a destination for kids with type 1 diabetes; Bronx Assemblyman Mark Gjonaj and a current patient. Families checked out the latest insulin pumps and related technologies at vendor displays, and connected with one another as they learned about new treatments. The kids participated in crafts and face painting, and enjoyed their tour of the zoo.
As Alvin Fisher’s health declined, he was not moving up the liver transplant list quickly enough. His Montefiore doctors knew they needed to find a new approach that would increase his odds of getting a donor liver faster. One possibility was to use a liver that otherwise would be discarded because of hepatitis-C infection in the organ. At the same time, new breakthrough treatments for hep-C have a greater than 95% cure rate. Putting this all together, Fisher’s doctors proposed this innovative solution for him. It was Fisher’s trust in his Montefiore doctors that led to his decision to go ahead with the groundbreaking option, to accept a potentially serious illness along with the organ that could save his life.
From left: Samuel Sigal, MD, Sarah Bellemare, MD, patient Alvin Fisher, and Milan Kinkhabwala, MD, Chief, Transplantation. Photo credit: ©Buck Ennis/Crain’s New York Business
LIVER IN A BOX. THEY
ALL HAVE A STORY.”
—Samuel Sigal, MD, Director of Clinical Hepatology, Moses Campus
In March, Fisher became the first patient in New York without hepatitis-C to receive a donor liver infected with hep-C. Sarah Bellemare, MD, Transplant Surgeon, and Assistant Professor of Surgery, headed the team that performed Fisher’s successful surgery. Since then, two other Montefiore patients have received hep-C donor organs. Fisher has completed one round of treatment for hep-C and is clear of the virus. Two other New York hospitals have followed Montefiore’s lead and several others are working out how to offer this option to their patients. In the meantime, Alvin Fisher has his life back and plans to return to college in the fall.
Read the whole story in Crain’s New York Business: https://goo.gl/771pcJ
Epic@Montefiore is getting a makeover. The upgrade rolls out October 6 at the Moses, Einstein, Wakefield, Hutchinson and Westchester Square campuses, as well as Montefiore Medical Group, Montefiore Faculty Practices, Montefiore Home Care and White Plains Hospital. Improvements include a more modern design and interface, streamlined flowsheets and enhancements to inpatient and Emergency Department care planning. Content will be easier to find and read, creating a more seamless workflow experience and better patient care.
Familiarize yourself with the new features and upgrades by reviewing the training materials available on the Epic@Montefiore intranet beginning on August 31.
GRANT FUNDS STUDY OF SMOKING CESSATION FOR OPIOID TREATMENT PATIENTS
Shadi Nahvi, MD, MS, Attending Physician, Internal Medicine, Montefiore, and Associate Professor, Medicine, Psychiatry and Behavioral Sciences, Einstein
“Smoking has become the leading cause of death for people struggling with substance use,” says Shadi Nahvi, MD, MS, Attending Physician, Internal Medicine, Montefiore, and Associate Professor, Medicine, Psychiatry and Behavioral Sciences, Einstein. Now, Montefiore and Einstein researchers will work to help opioid treatment patients kick cigarettes, thanks to a $3.4 million grant from the National Institutes of Health. Dr. Nahvi and her team found the medication varenicline effective in helping 10 percent of opioid treatment patients stop smoking. The grant will fund a study examining strategies to enhance the effectiveness within opioid treatment programs. “By simultaneously treating opioid and tobacco addiction, we can help people who are often left out of smoking cessation programs lead healthier lives.” Dr. Nahvi and her team will recruit 450 patients who smoke from Montefiore’s Division of Substance Abuse (DoSA).
NIH FUNDS CHAM AND EINSTEIN KIDNEY RESEARCHER TRAINING
For the 42nd consecutive year, the Division of Pediatric Nephrology at CHAM and Einstein received funding from the National Institutes of Health to train the next generation of researchers in kidney health. The $1.2 million training grant funds postdoctoral fellows over five years, allowing them to conduct research. More than 50 postdoctoral trainees over the past 42 years have collaborated on a variety of translational and clinical research projects that have improved care for children and adults with kidney diseases and disorders.
SEARCHING FOR WAYS TO KEEP PEOPLE HEALTHIER, FOR LONGER. JOIN US.
Albert Einstein College of Medicine is seeking adult volunteers for a research study evaluating possible beneficial effects of the medicine acarbose on aging.
WHY SHOULD I PARTICIPATE?
Age is the single largest risk factor for many major diseases like cancer, diabetes and heart disease. By taking part in the SAIL study, you will help us learn about the aging process and find out if medicine can delay the harmful effects of aging.
CAN I BE INCLUDED IN THIS STUDY?
You may be eligible for screening if you are:
At a screening visit, we will check to see if you are at risk for diabetes.
Volunteers will receive up to $360 at study completion and will be reimbursed for parking and transportation.
To find out if you can participate, contact: SAIL Study, Albert Einstein College of Medicine Diabetes/Endocrine Clinical Trials Unit. Call 718-839-7326 or email firstname.lastname@example.org.
Sponsored by BXMPOWERMENT & Montefiore Prevention Center. Free 18+ event with valid ID featuring music, drinks and food, rapid HIV testing and performances.
Monday, August 21 | 7:00 – 11:00 pm
Salsa Con Fuego
2297 Cedar Avenue, Bronx, New York
For questions and contributing opportunities, contact email@example.com.
Learn about how our program can help strengthen your relationship.
AT THIS OPEN HOUSE YOU AND YOUR PARTNER WILL:
Wednesday, September 6 | 6:00 – 8:00 PM
Open House for Spanish Speaking Couples
Wednesday, September 13 | 6:00 – 8:00 PM
Open House for English Speaking Couples
Contact Jackie at 914-268-7933 or visit www.montefiore.org/supporting-healthy-relationships for more details.